• Ethema Health posted revenue of $18.76 million, more than doubled from the prior year, including $10.85 million tied to the ERC acquisition.
• Operating loss narrowed to $260,135, improving 80.5%, while net loss widened to $2.18 million as interest expense climbed 145.5% to $1.39 million.
• Cash used in operating activities fell 93.5% to $0.03 million, while management estimated a $3.9 million funding need over the next 12 months.
• Late in 2025, a significant customer cut reimbursement rates; Ethema said it stopped certain services and began expense cuts in early 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ethema Health Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001903596-26-000271), on July 01, 2026, and is solely responsible for the information contained therein.